The COVID-19 pandemic proved the need for a globally coordinated response to accelerate scientific discovery to save lives. Yet, while a global approach was taken to vaccine development, it didn’t exist for therapeutics.
Our international focus is one of the reasons why the Cumming Global Centre for Pandemic Therapeutics is the first of its kind. We take a partnership approach to attract global research expertise from diverse disciplines, driving long-term impact. We currently collaborate with 30+ institutions in 10 countries worldwide.
Cumming Global Centre for Pandemic Therapeutics international network
